EPISODE · Jul 6, 2026 · 5 MIN
今天3分钟我们来聊聊4岁自闭症儿童接受6次干细胞治疗后,症状显著改善,尤其是语言能力与粗大运动技能方面
from 源于细胞BioInsid的个人播客
每100名儿童约1名患自闭症,传统干预见效慢。干细胞疗法针对免疫异常和神经炎症,土耳其案例中4岁男孩经治疗后语言等能力大幅提升,多项研究显示其安全性和潜力,但需更多大样本试验验证。 参考文献: Kabatas S, Civelek E, Savrunlu EC, Karaaslan U, Yıldız Ö, Karaöz E. Advances in the treatment of autism spectrum disorder: Wharton jelly mesenchymal stem cell transplantation. World J Methodol 2025; 15(1): 95857. DOI: 10.5662/wjm.v15.i1.95857 Dawson G, et al. Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder. Stem Cells Translational Medicine, 2017. Lv YT, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. Journal of Translational Medicine, 2013. 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊4岁自闭症儿童接受6次干细胞治疗后,症状显著改善,尤其是语言能力与粗大运动技能方面
No transcript for this episode yet
Similar Episodes
No similar episodes found.